EGFR and familial pancreatic carcinoma: As of yet, epidermal growth factor receptor (EGFR) inhibition has not shown clinical efficacy in pancreatic cancer,15 but no study has investigated the efficacy of EGFR inhibitors in periampullary adenocarcinoma in relation to morphology.